Rapid advances in multimodality therapy have not significantly improved the overall 5-yr survival of oral cancer patients in the past two decades, thereby underscoring the need for molecular therapeutics. The development of new treatment strategies for more effective management of oral cancer requir
Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells
✍ Scribed by Takashi Ishigami; Katsuhiro Uzawa; Morihiro Higo; Hitomi Nomura; Kengo Saito; Yoshikuni Kato; Dai Nakashima; Masashi Shiiba; Hiroki Bukawa; Hidetaka Yokoe; Tetsuya Kawata; Hisao Ito; Hideki Tanzawa
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- French
- Weight
- 532 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
To identify genes associated with radioresistant oral squamous cell carcinoma (OSCC), we compared gene expression signatures between OSCC cell lines exhibiting radioresistance and cells with radiosensitivity after X‐ray irradiation in a dose‐dependent manner using Affymetrix GeneChip analysis with Human Genome‐U133 plus 2.0 GeneChip. The microarray data identified 167 genes that were significantly overexpressed in radioresistant cells after X‐ray irradiation. Among the genes identified, 40 were mapped to 3 highly significant genetic networks identified by the Ingenuity Pathway Analysis tool. Gene ontology analysis showed that cancer‐related function had the highest significance. The 40 genes included 25 cancer‐related genes that formed 1 network and were categorized by function into growth and proliferation, apoptosis, and adhesion. Furthermore, real‐time quantitative reverse transcriptase–polymerase chain reaction showed that the mRNA expression levels of the 25 genes were higher in radioresistant cells than in radiosensitive cells in a dose‐dependent manner and in a time‐dependent manner. Our results suggest that the identified genes help to elucidate the molecular mechanisms of the radioresistance of OSCC and could be radiotherapeutic molecular markers for choosing the appropriate radiotherapy for this disease. © 2007 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract A high level of plasminogen activator inhibitor‐1 (PAI‐1 or __SERPINE1__) in tumor extracts is a marker of a poor prognosis in human cancers, including oral carcinomas. However, the mechanisms responsible for the upregulation of PAI‐1 in cancers remain unclear. Investigating specific PA
Previous studies of oral cancer have suggested that alterations of the p53 tumour suppressor gene occur early in the precancerous stage of development. However, these observations have been based on cross-sectional assessment of abnormal p53 protein staining by immunohistochemistry and may not neces
Recent studies have suggested that abnormalities in the adenomatous polyposis coli gene (AP C gene) are associated with the development not only of familial adenomatous polyposis coli (FAP) but also of cancers in digestive organs. In order to elucidate whether abnormalities of the APC gene could con